`_____________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`CARDIOCOM, LLC
`Petitioner
`v.
`ROBERT BOSCH HEALTHCARE SYSTEMS, INC.
`Patent Owner
`_____________________
`CASE IPR2013-00451
`Patent No. 7,587,469
`_____________________
`
`PATENT OWNER’S REPLY IN SUPPORT OF
`MOTION TO EXCLUDE EVIDENCE
`
`
`
`I.
`
`Dr. Stone’s Analysis of Analogous Art is Fundamentally Flawed.
`
`Cardiocom argues in its Response that Dr. Stone’s analysis of Wahlquist as
`
`analogous art should not be excluded because he was permitted to consider the
`
`specification of the ’469 patent. Resp., 1-2. Bosch does not dispute that one may
`
`consider the specification to determine the proper scope of the claimed invention.
`
`Dr. Stone, however, testified that, in considering the specification, he determined
`
`the field of endeavor of the ’469 patent to be even broader than what is actually
`
`claimed. Ex. 2024, 955:24-956:12; 1140:6-23. This of course violates Federal
`
`Circuit law. In re Klein, 647 F.3d 1343, 1348 (Fed. Cir. 2011). Incorrect
`
`statements of law of this sort must be excluded. Hebert v. Lisle Corp., 99 F.3d
`
`1109, 1117 (Fed. Cir. 1996).
`
`Dated: August 21, 2014
`
`Respectfully submitted,
`
`By:
`
`/Don Daybell/
`Don Daybell, Reg. No. 50,877
`Attorney for Patent Owner Robert Bosch
`Healthcare Systems, Inc.
`
`-1 -
`
`
`
`CERTIFICATION OF SERVICE (37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the above-captioned PATENT
`
`OWNER’S REPLY IN SUPPORT OF MOTION TO EXCLUDE EVIDENCE was
`
`served in its entirety on August 21, 2014, upon the following parties via electronic
`
`mail:
`
`Counsel for Petitioner
`
`Daniel W. McDonald
`Andrew J. Lagatta
`Merchant & Gould
`80 South 8th St., Suite 3200
`Minneapolis, MN 55402
`CardiocomIPR@merchantgould.com
`
`By:
`
`/Valerie Cloyd/
`Valerie Cloyd
`
`-2 -
`
`